Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 302

Full Length Research Paper

CD4 T-Lymphocytes, adherence and sociodemographic factors associated with viral load outcome of people living with HIV (PLHIV) on antiretroviral therapy in Lagos State, Nigeria

Oluwatosin Temitope Ogungbade
  • Oluwatosin Temitope Ogungbade
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar
Clifford Umeh
  • Clifford Umeh
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Omololuoye Majekodunmi
  • Omololuoye Majekodunmi
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Ogonnaya Kanu-Oji
  • Ogonnaya Kanu-Oji
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
John Paul Mbah
  • John Paul Mbah
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Bartholomew Ochonye
  • Bartholomew Ochonye
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Kalada Green
  • Kalada Green
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar
Elijah Mmokutmfon
  • Elijah Mmokutmfon
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Obinna Chigbundu
  • Obinna Chigbundu
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Onyeka Igboelina
  • Onyeka Igboelina
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Dolapo Ogundehin
  • Dolapo Ogundehin
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Gbenga Asaolu
  • Gbenga Asaolu
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Chika Obiora-Okafo
  • Chika Obiora-Okafo
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Augustine Idemudia
  • Augustine Idemudia
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Chukwuka Nwadike
  • Chukwuka Nwadike
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Babatunde Oyawola
  • Babatunde Oyawola
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Bayo Onimode
  • Bayo Onimode
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Betty Pius
  • Betty Pius
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Kunle Kakanfo
  • Kunle Kakanfo
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Pamela Gado
  • Pamela Gado
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Moses Katbi
  • Moses Katbi
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
David Onime
  • David Onime
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Ezekiel James
  • Ezekiel James
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Jameh Pius
  • Jameh Pius
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Omosalewa Oyelaran
  • Omosalewa Oyelaran
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Adebobola Bashorun
  • Adebobola Bashorun
  • National AIDS, Sexually Transmitted Infections Control and Hepatitis Programme (NASCP), Federal Ministry of Health, Abuja, Nigeria.
  • Google Scholar
Temitope Ilori
  • Temitope Ilori
  • National Agency for the Control of AIDS (NACA), Abuja, Nigeria.
  • Google Scholar
Kingston Omo-Emmanuel
  • Kingston Omo-Emmanuel
  • Office of HIV and TB, United States Agency for International Development (USAID), Abuja, Nigeria.
  • Google Scholar
Okpanachi Momoh
  • Okpanachi Momoh
  • Heartland Alliance Limited by Guarantee (HALG), Abuja, Nigeria.
  • Google Scholar
Chukwuebuka Ejeckam
  • Chukwuebuka Ejeckam
  • West Africa Centre for Public Health and Development (WACPHD), an affiliate of the Institute of Global Public Health, University of Manitoba, Winnipe Canada.
  • Google Scholar


  •  Received: 28 August 2024
  •  Accepted: 25 October 2024
  •  Published: 31 March 2025

References

Agegn Gwadu A, Abebe Tegegne M, Belay Mihretu K, Tegegne AS (2023). Predictors of Viral Load Outcome over Time among HIV Infected Adults Under HAART in Zewditu Memorial Hospital, Ethiopia: A Retrospective Study. HIV/AIDS-Research and Palliative Care pp. 29-40.
Crossref

 

Atnafu GT, Moges NA, Wubie M, Gedif G (2022). Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infection and drug resistance pp. 261-274.
Crossref

 

Bassey AE, Miteu GD (2023). A review of current trends in HIV epidemiology, surveillance, and control in Nigeria. Annals of Medicine and Surgery 85(5):1790-5.
Crossref

 

Belete MB, Bitew A, Mulatu K (2024). Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study. Plos one 19(5): e0303243.
Crossref

 

Bvochora T, Satyanarayana S, Takarinda KC, Bara H, Chonzi P, Komtenza B, Duri C, Apollo T (2019). Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: operational issues. PloS one.5;14(2):e0211326.
Crossref

 

Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, Godefay H (2020). HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infectious Diseases 20:1-10.
Crossref

 

Ebua AF, Shey ND, Ngouamkeu NEK, Yannick NAD (2023). Predictors and Facilitators of High Viral Load in HIV Positive Persons on Antiretroviral Treatment in the East Region of Cameroon. Texila International Journal of Public Health 10(3):1-16.
Crossref

 

Kapiamba G, Masango T, Mphuthi D (2016). Antiretroviral adherence and virological outcomes in People Living with HIV (PLHIV) in Ugu district, KwaZulu-Natal province. African Journal of AIDS Research 15(3):195-201
Crossref

 

Haas AD, Radin E, Hakim AJ, Jahn A, Philip NM, Jonnalagadda S, Justman JE (2020). Prevalence of nonsuppressed viral load and associated factors among HIV?positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population?based nationally representative surveys. Journal of the International AIDS Society 23(11):e25631.
Crossref

 

Hakizayezu F, Biracyaza E, Niyompano H, Umubyeyi A (2022). The Frequency and Predictors of Unsuppressed HIV Viral Load among People with HIV in Nyaruguru District, Rwanda. HIV/AIDS-Research and Palliative Care pp. 381-395.
Crossref

 

Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Martin JN (2003). Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. Aid 17(13):1907-1915.
Crossref

 

Hussen S, Mama M, Mekonnen B, Shegaze M, Boti N, Shure M (2019). Predictors of time to viral load suppression of adult PLWHIV on ART in Arba Minch General Hospital: a Follow-up Study. Ethiopian journal of health sciences 29(6):751-758.
Crossref

 

Lopes J (2021). A secondary analysis using individual patient data of two pragmatic cluster-randomized control trials evaluating 3 monthly and 6 monthly community-based multi-month dispensing of antiretroviral treatment in Southern Africa (Doctoral dissertation, Stellenbosch: Stellenbosch University.

 

Mboggo E, Mtisi E, Mushy SE, Mkawe S, Ngalesoni F, Muya A, Mlay B S (2024). Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania. BMC Infectious Diseases 24(1): 312.
Crossref

 

Miller V, Staszewski S, Sabin C, Carlebach A, Rottmann C, Weidmann E., Phillips AN (1999). CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy-Induced Suppression of Human Immunodeficiency Virus Load. The Journal of Infectious Diseases 180(2):530-533.
Crossref

 

Mugo C, Zubayr B, Ezeokafor N, Oyawola B, Ekele DO, Madueke L, Semo BW (2023). Effect of Dolutegravir and Multimonth Dispensing on Viral Suppression among Children with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 93(3) 229-236.
Crossref

 

Muhie NS (2024). Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: Retrospective cohort study. Scientific Reports 14(1):1-10.
Crossref

 

Ngandu NK, Lombard CJ, Mbira TE, Puren A, Waitt C, Prendergast AJ, Goga AE (2022). HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey BMJ open 12(3):e058347.
Crossref

 

Ogbaji S, Ebirim CIC, Dozie UW, Oguizu AD (2023). Assessment of Viral Suppression among HIV Seropositive Adults on Dolutegravir-Based Regimen in Federal Medical Centre Owerri, Nigeria. Engineering and Scientific International Journal 10(2):18-24.

 

Oyuga R, Amadi E, Blanco N, Ndaga A, Abuy K, Oneya D, Lavoie MCC (2022). Effects of multi-month dispensing on viral suppression and continuity in treatment among children living with HIV aged 2 to 9 years: a cohort study in Western Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes pp. 10-1097

 

Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Swiss HIV Cohort Study (2001). HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. Jama 286(20):2560-2567.
Crossref

 

Plymoth M, Sanders EJ, Van Der Elst EM, Medstrand P, Tesfaye F, Winqvist, N, Björkman P (2020). Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia. Plos one 15(12):e0244066.
Crossref

 

Policy Fact Sheet (2023). Global AIDS Monitoring (UNAIDS/WHO/UNICEF) and WHO Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes.

 

Semo BW, Ezeokafor NA, Oyawola B, Mugo C (2023). Effect of Multi-Month Dispensing on Viral Suppression for Newly Enrolled Adolescents and Adults in Northern Nigeria. HIV/AIDS-Research and Palliative Care pp. 697-704.
Crossref

 

Tomescu S, Crompton T, Adebayo J, Akpan F, Dauda DS, Allen Z, Pisa P. (2023). Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021. BMJ open 13(5):e065950.
Crossref

 

UNAIDS (2023). Epidemiological estimates. Fact Sheet.

View

 

Ukaegbu E, Alibekova R, Ali S, Crape B, Issanov A (2022). Trends of HIV/AIDS knowledge and attitudes among Nigerian women between 2007 and 2017 using Multiple Indicator Cluster Survey data. BMC Public Health 22(1):440.
Crossref

 

Waju B, Dube L, Ahmed M, Assefa SS (2021). Unsuppressed viral load level in public health facilities: non-virological predictors among adult antiretroviral therapy users in southwestern Ethiopia. HIV/AIDS-Research and Palliative Care Pp. 513-526.
Crossref

 

Wakooko P, Gavamukulya Y, Wandabwa JN (2020). Viral load Suppression and Associated Factors among HIV Patients on Antiretroviral Treatment in Bulambuli District, Eastern Uganda: A Retrospective Cohort Study. Infectious Diseases: Research and Treatment Pp.13:1-9.
Crossref

 

World Health Organization (WHO) (2024). Implementing the global health sector strategies on HIV, viral hepatitis, and sexually transmitted infections, 2022-2030: report on progress and gaps. Geneva: World Health Organization.